Lactiga secures its American patent

Jun 9, 2021 | Announcements

Lactiga received notification of issuance of its US patent, completing the first phase of its intellectual property portfolio.

Lactiga featured in the Globe and Mail

Lactiga was featured in The Globe and Mail for its COVID-19 therapeutics program:

Lactiga featured in the Toronto Star

Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers: